C12N 2760/20244
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2760/20244 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 6
- Inventors
- 31
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of use of oncolytic virus like vesicles17 Mar 2026US 12,577,585 B2Carogen Corporation
- VSV chimeric vectors13 Jan 2026US 12,522,844 B2Boehringer Ingelheim International GmbH
- Engineered enveloped vectors and methods of use thereof29 Jul 2025US 12,371,689 B2GigaMune, Inc.
- Chimeric vesiculoviruses and methods of use27 May 2025US 12,311,000 B2Mayo Foundation for Medical Education and Research
- Replication-competent VSV-HIV Env vaccines27 Mar 2018US 9,925,258 B2International AIDS Vaccine Initiative
- Engineered enveloped vectors and methods of use thereof21 May 2026US 2026/0139247 A1GigaMune, Inc.
- Process for producing a purified rhabdovirus from cell culture26 Mar 2026US 2026/0085294 A1Boehringer Ingelheim International GmbH
- Engineered enveloped vectors and methods of use thereof29 Feb 2024US 2024/0067958 A1GigaMune, Inc.
- Compositions and methods of use of oncolytic virus like vesicles2 Mar 2023US 2023/0063041 A1Carogen Corporation
- Chimeric vesiculoviruses and methods of use1 Sep 2022US 2022/0273740 A1Mayo Foundation for Medical Education and Research
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.